VISTIN PHARMA ASA: årsregnskap 2018 vs 2017
Shrank 107% on revenue, fresh owner capital
approved 2019-04-24; registry 2019-06-26; journal 2019 541694
Summary
What changed
Comparing Årsregnskap 2018 with 2017 for VISTIN PHARMA ASA. Revenue 83.12m NOK → -5.50m NOK (-106.6%). Equity 112.93m NOK → 338.5k NOK.
On the constructive side: cash rose; owners injected capital; payroll decreased. Pressures included: revenue fell; equity eroded.
Also worth watching: book investments changed. All figures are taken from the published annual accounts for VISTIN PHARMA ASA.
At a glance
Scorecard
What improved
-
↑
Cash rose
Bank deposits 41.37m NOK → 141.36m NOK (+241.7% YoY). Calculated
-
↑
Owners injected capital
Paid-in equity rose 112.93m NOK → 320.52m NOK (+207.59m NOK). Reported fact
-
↑
Payroll decreased
Salary cost 1.82m NOK → 1.61m NOK. Calculated
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 83.12m NOK to -5.50m NOK (-106.6% YoY). Calculated
-
↓
Equity eroded
Book equity 112.93m NOK → 338.5k NOK (equity ratio 85.2% → 98.3%). Calculated
Things to notice
-
·
Book investments changed
Investment / intangible book value 79.62m NOK → 194.63m NOK. Reported fact